Impact of Community-Based Education on Knowledge, Beliefs, and Screening Behaviors for Non-Communicable Diseases in Sri Lanka: A Randomized Controlled Trial.

Last registered on September 19, 2025

Pre-Trial

Trial Information

General Information

Title
Impact of Community-Based Education on Knowledge, Beliefs, and Screening Behaviors for Non-Communicable Diseases in Sri Lanka: A Randomized Controlled Trial.
RCT ID
AEARCTR-0016772
Initial registration date
September 18, 2025

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
September 19, 2025, 10:21 AM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Affiliation
Hiroshima University

Other Primary Investigator(s)

Additional Trial Information

Status
In development
Start date
2025-10-15
End date
2026-03-30
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
Globally, non-communicable diseases (NCDs) are a major public health concern, and in Sri Lanka they account for 84% of all deaths, highlighting their critical impact on population health. Despite the availability of Healthy Lifestyle Centers (HLCs) for NCD screening and education, uptake remains at 2.9% nationally and 6.8% in the Bellana Primary Medical Care Unit (PMCU) area, which is far below the national target of 40%. Therefore, there is an urgent need for effective, deployable, community-driven strategies to increase screening participation to early detection of NCDs.

This randomized controlled trial (RCT) aims to assess the effectiveness of educational interventions in enhancing NCD-related knowledge, modifying health beliefs and increasing screening uptake among adults aged 35–65 years residing in the Bellana PMCU catchment area of the Kalutara District, Sri Lanka. The study will be conducted from August 2025 to February 2026. A total of 450 participants will be enrolled and randomized equally into three groups (n=150 per group). The primary outcome is NCD screening uptake; secondary outcomes include changes in knowledge and health beliefs. Intervention Group 1 (T1, n=150) will receive a structured awareness session on NCD risk factors, symptoms, prevention, and services of HLC, followed by a group discussion and an educational leaflet. Intervention Group 2 (T2, n=150) will receive the same awareness session and a group discussion. The control group will participate in a placebo session on awareness of child abuse and a group discussion (n = 150). The self-administered questionnaire will include demographic information, NCD knowledge (10 items), and health beliefs based on the Health Belief Model (HBM) (24 items). The Content Validity Index (CVI) will be assessed by four experts, each with over ten years of experience in NCD control, with a target value above 0.90. Internal consistency will be assessed in a pilot study with 30 participants, with reliability coefficients expected to exceed 0.7.

Data will be collected immediately before and after the intervention using the validated questionnaire, with follow-up assessments will be conducted at two and three months after interventions to confirm increased NCD screening uptake by reviewing the Participants’ Register at PMCU Bellana. Data will be cleaned and analyzed using R (version 4.5.1) software. Analyses will follow the intention-to-treat principle, with per-protocol analyses conducted for sensitivity. Baseline characteristics will be summarized using descriptive statistics, and group differences will be evaluated using Chi-square tests for categorical variables and t-tests or Analysis of Variance (ANOVA) for continuous variables, depending on data distribution. Changes in knowledge and health belief scores will be analyzed using paired t-tests, ANOVA, and post-hoc comparisons, while screening uptake will be compared using Chi-square tests and risk ratios. To examine the underlying mechanisms, causal mediation analysis will be performed using logistic regression-based models. Missing data will be examined through sensitivity analyses, with statistical significance set at p < 0.05.

To date, no RCT in Sri Lanka has evaluated community-based educational interventions, such as awareness sessions, group discussions, and educational leaflets, within an HBM-based framework. Ethics approval will be obtained from the Ethics Review Committee of the National Institute of Health Sciences, Kalutara and Hiroshima University, prior to implementation. Written informed consent will be obtained from all eligible participants, and confidentiality will be strictly maintained. The interventions are designed to be non-invasive and culturally appropriate, with the potential to inform optimization of HLCs, support Sustainable Development Goal (SDG) target 3.4 on reducing premature mortality from NCDs, and provide a replicable model for other low- and middle-income countries (LMICs).
External Link(s)

Registration Citation

Citation
Badugama Hewage, Nilmini Palika Priyanthi. 2025. "Impact of Community-Based Education on Knowledge, Beliefs, and Screening Behaviors for Non-Communicable Diseases in Sri Lanka: A Randomized Controlled Trial.." AEA RCT Registry. September 19. https://doi.org/10.1257/rct.16772-1.0
Experimental Details

Interventions

Intervention(s)
The study will consist of three arms. Participants in Intervention 1 (T1) will receive a structured awareness session on NCD risk factors, symptoms, prevention, and services of HLC, followed by a group discussion and an educational leaflet covering the important information. Participants in Intervention 2 (T2) will receive only the same awareness session and discussion. The control group will receive placebo training in the form of an awareness session on child abuse, which is unrelated to NCD prevention and followed by a group discussion, to ensure participant engagement while avoiding exposure to the specific intervention content.

The awareness sessions for T1 and T2 will be delivered by Public Health Nursing Officers (PHNOs). Sessions will begin with a group presentation that explains the current NCD situation in Sri Lanka, key risk factors, symptoms, and consequences. The importance of screening and the services offered at HLCs will also be highlighted, with emphasis on the benefits of early detection. After the presentation, participants will join small discussion groups for interactive question-and-answer sessions to reinforce understanding and encourage practical application. Participants will be divided into fifteen small groups for interactive discussions facilitated by Public Health Midwives, PHNOs, and a Medical Officer from the Bellana PMCU. In the control group, a Probation Officer delivered a session on child protection, which was unrelated to NCDs. Participants were divided into fifteen small groups for interactive discussions, facilitated by Probation Officers. To avoid contamination across groups, the three interventions will be conducted in three separate locations.

The leaflet used in the intervention will contain the content as the standard informational leaflet developed by the NCD Unit, Ministry of Health, Sri Lanka. It will cover key topics such as the common types and causes of NCDs, symptoms and effects, methods for controlling, and available screening facilities at HLCs. The leaflet will serve as a reinforcement tool for the awareness session, providing participants with a take-home resource for continued reference.

This study will follow a single-blind design, where outcome assessors and data analysts will remain blinded to group allocation until completion of the analysis. Participants will be aware of the intervention they receive, but blinding of assessors and analysts will help minimize observer and analytical bias.
Intervention Start Date
2025-11-15
Intervention End Date
2025-11-30

Primary Outcomes

Primary Outcomes (end points)
The Primary outcome will be the actual uptake of NCD screening. This outcome will be measured at two-time points: the first follow-up, conducted two months after the intervention, and the second follow-up, conducted three months after the intervention. Data will be obtained from Participants’ Register at PMCU Bellana to verify screening uptake.
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
The secondary outcomes of the study will include participants’ knowledge of NCD risk factors, symptoms, and prevention, as well as their health beliefs regarding NCD screening. Both outcomes will be measured using the questionnaire at baseline and endline stages.
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
A self-administered questionnaire will be used to collect data from the recruited participants. It will be translated from English into both Sinhala and Tamil. The questionnaire will consist of three components: (1) socio-demographic information, (2) knowledge of NCD risk factors, symptoms, and prevention, and (3) the NCD health beliefs.

Knowledge of NCDs will be measured using a structured instrument developed with input from an expert panel. The tool consists of 10 items adapted from the questionnaire by Gamage and Jayawardana (2018), which was originally based on the World Health Organization (WHO) STEPwise Approach to Surveillance (STEPS) NCD risk factor questionnaire and the Pan American Health Organization (PAHO) NCD Surveillance Toolkit. For this study, a consultant, a Medical Officer for NCDs, a PHNO, and a researcher with expertise in questionnaire design refined the pool of items to ensure clarity, contextual appropriateness, and relevance. The final 10 items assess knowledge of major NCDs, focusing on risk factors, symptoms, and preventive measures. The original tool contained 39 questions; this was reduced to 10 to minimize respondent burden while retaining adequate coverage of the essential domains of NCD knowledge.
The level of NCD health beliefs will be assessed based on the constructs of the HBM. This assessment will follow the framework used in previous studies by Kaba et al. (2017) and Sung-Heui et al. (2022). In their approach, perceived susceptibility was measured using five items, perceived severity with five items, perceived benefits with seven items, perceived barriers with seven items, perceived cues to action with six items, and perceived self-efficacy with five items. All items were rated on a 5-point Likert scale (strongly disagree, disagree, neutral, agree, strongly agree). For the present study, the same framework was adopted, with 24 items in total (four items for each construct). The same expert panel reviewed and refined these items to ensure clarity, contextual relevance, and suitability. Reducing the number of items per construct was intended to minimize respondent burden while maintaining sufficient coverage of the key domains of NCD health beliefs.

Experimental Design Details
Not available
Randomization Method
A simple random sampling method will be used
Randomization Unit
individual
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
15 GNDs
Sample size: planned number of observations
450 units
Sample size (or number of clusters) by treatment arms
450 units
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
The required sample size will be calculated using the following formula for comparing proportions as described by Lwanga and Lemeshow (1991).
IRB

Institutional Review Boards (IRBs)

IRB Name
Research Ethics Clearance Board, Hiroshima University
IRB Approval Date
2025-09-06
IRB Approval Number
HR-LPES-003255